Blood brain barrier-on-a-chip permeation to model neurological diseases using microfluidic biosensors
DOI:
https://doi.org/10.60087/jklst.v3.n4.p78Keywords:
Blood-Brain Barrier , Organ-On-Chip, Microfluidics, Biosensor, Disease Modeling , Personalised MedicineAbstract
The need to understand human body functions, monitor disease progression, and advance in drug development have consistently been major driving forces for medical innovations and advancements. Organ-on-a-Chip technology, particularly Blood-brain-barrier (BBB)-on-chip technology, creates an avenue to closely replicate the brain environment and provides real-time monitoring of cells. Located at the interface between the blood and the brain parenchyma, the blood-brain barrier is crucial for protecting the brain due to its semi-permeable nature, and is responsible for regulating the movement of molecules between the blood and the brain. Therefore its integrity and perfect functionality are essential for the unperturbed functioning of the central nervous system. The lack of effective in-vitro models to investigate these diseases due to various technical and economic limitations poses a significant challenge. Moreover, the use of in-vivo models involving other primates and rodents for experimentation further poses a challenge due to physiological variations between humans and other species and has ethical constraints. Our study explores how the BBB-on-chip overcomes a lot of these limitations posed by the other in-vitro and in-vivo models, making it a more efficient and accurate model to investigate the blood-brain barrier. The study further explains the evolution, applications, and future prospects of the BBB on-chip technologies.
Downloads
References
J. D. Steinmetz et al., “Global, regional, and national burden of disorders affecting the nervous system, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021,” The Lancet Neurology, vol. 23, no. 4, Mar. 2024, doi: https://doi.org/10.1016/s1474-4422(24)00038-3.
A. M. R. https ://www.alliedmarketresearch.com, “Organ-on-Chip Market Size & Growth Statistics By 2030,” Allied Market Research. https://www.alliedmarketresearch.com/organ-on-chip-market#:~:text=The%20global%20organ%2Don%2Dchip
M. Bundgaard and N. J. Abbott, “All vertebrates started out with a glial blood-brain barrier 4-500 million years ago,” Glia, vol. 56, no. 7, pp. 699–708, May 2008, doi: https://doi.org/10.1002/glia.20642.
Y. Persidsky, S. H. Ramirez, J. Haorah, and G. D. Kanmogne, “Blood-brain barrier: structural components and function under physiologic and pathologic conditions,” Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology, vol. 1, no. 3, pp. 223–36, 2006, doi: https://doi.org/10.1007/s11481-006-9025-3.
N. M. O’Brown, S. J. Pfau, and C. Gu, “Bridging barriers: a comparative look at the blood–brain barrier across organisms,” Genes & Development, vol. 32, no. 7–8, pp. 466–478, Apr. 2018, doi: https://doi.org/10.1101/gad.309823.117.
N. J. Abbott, A. A. K. Patabendige, D. E. M. Dolman, S. R. Yusof, and D. J. Begley, “Structure and Function of the Blood–brain Barrier,” Neurobiology of Disease, vol. 37, no. 1, pp. 13–25, Jan. 2010, doi: https://doi.org/10.1016/j.nbd.2009.07.030.
R. Daneman and A. Prat, “The Blood–Brain Barrier,” Cold Spring Harbor Perspectives in Biology, vol. 7, no. 1, 2015, doi: https://doi.org/10.1101/cshperspect.a020412.
L. Pulzova, M. R. Bhide, and K. Andrej, “Pathogen translocation across the blood-brain barrier,” FEMS Immunology & Medical Microbiology, vol. 57, no. 3, pp. 203–213, Dec. 2009, doi: https://doi.org/10.1111/j.1574-695x.2009.00594.x.
Gupte, P.; Dhingra, K.; Saloni , V. Precision Gene Editing Strategies With CRISPR-Cas9 for Advancing Cancer Immunotherapy and Alzheimer’s Disease. J. Knowl. Learn. Sci. Technol. 2024, 3 (4), 11-21. https://doi.org/10.60087/jklst.v3.n4.p11.
A. MacIntyre, C. J. Hammond, C. Scott. Little, D. M. Appelt, and B. J. Balin, “Chlamydia pneumoniaeinfection alters the junctional complex proteins of human brain microvascular endothelial cells,” FEMS Microbiology Letters, vol. 217, no. 2, pp. 167–172, Dec. 2002, doi: https://doi.org/10.1111/j.1574-6968.2002.tb11470.x.
“https://www.cancer.gov/publications/dictionaries/cancer-terms/def/microfluidic-device,” www.cancer.gov, Feb. 02, 2011. https://www.cancer.gov/publications/dictionaries/cancer-terms/def/microfluidic-device
L. A. Low, C. Mummery, B. R. Berridge, C. P. Austin, and D. A. Tagle, “Organs-on-chips: into the next decade,” Nature Reviews Drug Discovery, vol. 20, pp. 1–17, Sep. 2020, doi: https://doi.org/10.1038/s41573-020-0079-3.
V. Guarino, A. Zizzari, M. Bianco, G. Gigli, L. Moroni, and V. Arima, “Advancements in modelling human blood brain-barrier on a chip,” Biofabrication, vol. 15, no. 2, Feb. 2023, doi: https://doi.org/10.1088/1758-5090/acb571.
S. K. Srivastava, G. W. Foo, N. Aggarwal, and M. W. Chang, “Organ-on-chip technology: Opportunities and challenges,” Biotechnology Notes, vol. 5, pp. 8–12, Jan. 2024, doi: https://doi.org/10.1016/j.biotno.2024.01.001.
T.-E. Park et al., “Hypoxia-enhanced Blood-Brain Barrier Chip recapitulates human barrier function and shuttling of drugs and antibodies,” Nature Communications, vol. 10, no. 1, p. 2621, Jun. 2019, doi: https://doi.org/10.1038/s41467-019-10588-0.
M. Li et al., “Blood–brain barrier microfluidic chips and their applications,” Organs-on-a-Chip, vol. 5, p. 100027, Dec. 2023, doi: https://doi.org/10.1016/j.ooc.2023.100027.
H. J. Pandya et al., “A microfluidic platform for drug screening in a 3D cancer microenvironment,” Biosensors and Bioelectronics, vol. 94, pp. 632–642, Aug. 2017, doi: https://doi.org/10.1016/j.bios.2017.03.054.
H. J. Pandya et al., “Label-free electrical sensing of bacteria in eye wash samples: A step towards point-of-care detec-tion of pathogens in patients with infectious keratitis,” Biosensors and Bioelectronics, vol. 91, pp. 32–39, May 2017, doi: https://doi.org/10.1016/j.bios.2016.12.035.
M. Safavieh et al., “Paper microchip with a graphene-modified silver nano-composite electrode for electrical sensing of microbial pathogens,” Nanoscale, vol. 9, no. 5, pp. 1852–1861, 2017, doi: https://doi.org/10.1039/c6nr06417e.
GhavamiNejad P, GhavamiNejad A, Zheng H, Dhingra K, Samarikhalaj M, Poudineh M., “A Conductive Hydrogel Mi-croneedle‐Based Assay Integrating PEDOT:PSS and Ag‐Pt Nanoparticles for Real‐Time, Enzyme‐Less, and Electro-chemical Sensing of Glucose,” Advanced Healthcare Materials, vol. 12, no. 1, Oct. 2022, doi: https://doi.org/10.1002/adhm.202202362.
S. N. Bhatia and D. E. Ingber, “Microfluidic organs-on-chips,” Nature biotechnology, vol. 32, no. 8, pp. 760–72, 2014, doi: https://doi.org/10.1038/nbt.2989.
D. Huh et al., “A Human Disease Model of Drug Toxicity–Induced Pulmonary Edema in a Lung-on-a-Chip Microdevice,” Science Translational Medicine, vol. 4, no. 159, pp. 159ra147–159ra147, Nov. 2012, doi: https://doi.org/10.1126/scitranslmed.3004249.
S. Odinotski et al., “A Conductive Hydrogel‐Based Mi-croneedle Platform for Real‐Time pH Measurement in Live Animals,” Small, vol. 18, no. 45, Sep. 2022, doi: https://doi.org/10.1002/smll.202200201.
J. Li et al., “An Overview of Organs-on-Chips Based on Deep Learning,” Research, vol. 2022, Jan. 2022, doi: https://doi.org/10.34133/2022/9869518.
M. Verhulsel, M. Vignes, S. Descroix, L. Malaquin, D. M. Vignjevic, and J.-L. Viovy, “A review of microfabrication and hydrogel engineering for micro-organs on chips,” Biomaterials, vol. 35, no. 6, pp. 1816–1832, Feb. 2014, doi: https://doi.org/10.1016/j.biomaterials.2013.11.021.
F. Sivandzade and L. Cucullo, “In-vitro blood–brain barrier modeling: A review of modern and fast-advancing technologies,” Journal of Cerebral Blood Flow & Metabolism, vol. 38, no. 10, pp. 1667–1681, Jul. 2018, doi: https://doi.org/10.1177/0271678x18788769.
L. Jiang, S. Li, J. Zheng, Y. Li, and H. Huang, “Recent Progress in Microfluidic Models of the Blood-Brain Barrier,” Micromachines, vol. 10, no. 6, p. 375, Jun. 2019, doi: https://doi.org/10.3390/mi10060375.
T. G. Schreiner, I. Creangă-Murariu, B. I. Tamba, N. Lucanu, and B. O. Popescu, Biomolecules, vol. 12, no. 8, p. 1136, Aug. 2022, doi: https://doi.org/10.3390/biom12081136.
J. Yoon, J. Kim, Z. Shah, A. Awasthi, A. Mahajan, and Y. Kim, “Advanced Human BBB‐on‐a‐Chip: A New Platform for Alzheimer’s Disease Studies,” Advanced Healthcare Materials, vol. 10, no. 15, p. 2002285, Jun. 2021, doi: https://doi.org/10.1002/adhm.202002285.
H. K. Alajangi et al., “Blood–brain barrier: emerging trends on transport models and new-age strategies for therapeutics intervention against neurological disorders,” Molecular Brain, vol. 15, no. 1, Jun. 2022, doi: https://doi.org/10.1186/s13041-022-00937-4.
Dona, S. H. Ramirez, and A. M. Andrews, “A Next-Generation 3D Tissue-Engineered Model of the Human Brain Microvasculature to Study the Blood-Brain Barrier,” Bioengineering, vol. 10, no. 7, pp. 817–817, Jul. 2023, doi: https://doi.org/10.3390/bioengineering10070817.
Dona et al., “The Use of Tissue Engineering to Fabricate Perfusable 3D Brain Microvessels in vitro,” Frontiers in physiology, vol. 12, Aug. 2021, doi: https://doi.org/10.3389/fphys.2021.715431.
N. J. Abbott, L. Rönnbäck, and E. Hansson, “Astrocyte–endothelial interactions at the blood–brain barrier,” Nature Reviews Neuroscience, vol. 7, no. 1, pp. 41–53, Jan. 2006, doi: https://doi.org/10.1038/nrn1824.
Kulkarni S, Dhingra K, Verma S., "Applications of CMUT Technology in Medical Diagnostics: From Photoa-coustic to Ultrasonic Imaging", International Journal of Science and Research (IJSR), Volume 13 Issue 6, June 2024, pp. 1264-1269, https://www.ijsr.net/ar-chive/v13i6/SR24619062609.pdf.
B. T. Hawkins and T. P. Davis, “The Blood-Brain Barrier/Neurovascular Unit in Health and Disease,” Pharmacological Reviews, vol. 57, no. 2, pp. 173–185, May 2005, doi: https://doi.org/10.1124/pr.57.2.4.
M. A. Erickson and W. A. Banks, “Blood–Brain Barrier Dysfunction as a Cause and Consequence of Alzheimer’s Disease,” Journal of Cerebral Blood Flow & Metabolism, vol. 33, no. 10, pp. 1500–1513, Aug. 2013, doi: https://doi.org/10.1038/jcbfm.2013.135.
N. Pokhodylo, “Synthesis of 1,2,3-Triazole Derivatives and Evaluation of their Anticancer Activity,” Scientia Pharmaceutica, vol. 81, no. 3, pp. 663–676, 2013, doi: https://doi.org/10.3797/scipharm.1302-04.
N. Gertsik, D.-M. Chau, and Y.-M. Li, “γ-Secretase Inhibitors and Modulators Induce Distinct Conformational Changes in the Active Sites of γ-Secretase and Signal Peptide Peptidase,” ACS chemical biology, vol. 10, no. 8, pp. 1925–1931, Aug. 2015, doi: https://doi.org/10.1021/acschembio.5b00321.
H. S. Kwon and S.-H. Koh, “Neuroinflammation in neurodegenerative disorders: the roles of microglia and astrocytes,” Translational Neurodegeneration, vol. 9, no. 1, Nov. 2020, doi: https://doi.org/10.1186/s40035-020-00221-2.
K. J. Mitchell et al., “Ancient DNA reveals elephant birds and kiwi are sister taxa and clarifies ratite bird evolution,” Science, vol. 344, no. 6186, pp. 898–900, May 2014, doi: https://doi.org/10.1126/science.1251981.
N. J. Abbott, “Physiology of the blood–brain barrier and its consequences for drug transport to the brain,” International Congress Series, vol. 1277, pp. 3–18, Apr. 2005, doi: https://doi.org/10.1016/j.ics.2005.02.008.
Marián Mantecón-Oria, M. Rivero, Nazely Diban, and A. Urtiaga, “On the quest of reliable 3D dynamic in vitro blood-brain barrier models using polymer hollow fiber membranes: Pitfalls, progress, and future perspectives,” Frontiers in Bioengineering and Biotechnology, vol. 10, Nov. 2022, doi: https://doi.org/10.3389/fbioe.2022.1056162.
J. Kim, S.-A. Shin, C. S. Lee, and H. J. Chung, “An Improved In Vitro Blood-Brain Barrier Model for the Evaluation of Drug Permeability Using Transwell with Shear Stress,” Pharmaceutics, vol. 16, no. 1, p. 48, Jan. 2024, doi: https://doi.org/10.3390/pharmaceutics16010048.
A. Prashanth et al., “Are In Vitro Human Blood–Brain–Tumor-Barriers Suitable Replacements for In Vivo Models of Brain Permeability for Novel Therapeutics?,” Cancers, vol. 13, no. 5, p. 955, Feb. 2021, doi: https://doi.org/10.3390/cancers13050955.
Y. He, Y. Yao, S. E. Tsirka, and Y. Cao, “Cell-Culture Models of the Blood–Brain Barrier,” Stroke, vol. 45, no. 8, pp. 2514–2526, Aug. 2014, doi: https://doi.org/10.1161/strokeaha.114.005427.
M. Zakharova et al., “Multiplexed blood–brain barrier organ-on-chip,” Lab on a Chip, vol. 20, no. 17, pp. 3132–3143, 2020, doi: https://doi.org/10.1039/d0lc00399a.
S. Santaguida, D. Janigro, M. Hossain, E. Oby, E. Rapp, and L. Cucullo, “Side by side comparison between dynamic versus static models of blood–brain barrier in vitro: A permeability study,” Brain Research, vol. 1109, no. 1, pp. 1–13, Sep. 2006, doi: https://doi.org/10.1016/j.brainres.2006.06.027.
M. E. Boutin, L. L. Kramer, L. L. Livi, T. Brown, C. Moore, and D. Hoffman-Kim, “A three-dimensional neural spheroid model for capillary-like network formation,” Journal of Neuroscience Methods, vol. 299, pp. 55–63, Apr. 2018, doi: https://doi.org/10.1016/j.jneumeth.2017.01.014.
C.-F. Cho et al., “Blood-brain-barrier spheroids as an in vitro screening platform for brain-penetrating agents,” Nature Communications, vol. 8, no. 1, p. 15623, Jun. 2017, doi: https://doi.org/10.1038/ncomms15623.
Nandita Rahatekar Singh et al., “A hydrogel model of the human blood-brain barrier using differentiated stem cells,” vol. 18, no. 4, pp. e0283954–e0283954, Apr. 2023, doi: https://doi.org/10.1371/journal.pone.0283954.
S. Correia Carreira, R. Begum, and A. W. Perriman, “3D Bioprinting: The Emergence of Programmable Biodesign,” Advanced Healthcare Materials, vol. 9, no. 15, p. 1900554, Aug. 2019, doi: https://doi.org/10.1002/adhm.201900554.
Y. Li, J. Liu, S. Xu, and J. Wang, “3D Bioprinting: An Important Tool for Tumor Microenvironment Research,” International Journal of Nanomedicine, vol. Volume 18, pp. 8039–8057, Dec. 2023, doi: https://doi.org/10.2147/ijn.s435845.
A. Marino et al., “A 3D Real-Scale, Biomimetic, and Biohybrid Model of the Blood-Brain Barrier Fabricated through Two-Photon Lithography,” Small, vol. 14, no. 6, p. 1702959, Dec. 2017, doi: https://doi.org/10.1002/smll.201702959.
W. Bi, S. Cai, T. Lei, and L. Wang, “Implementation of blood-brain barrier on microfluidic chip: Recent advance and future prospects,” Ageing Research Reviews, vol. 87, p. 101921, Jun. 2023, doi: https://doi.org/10.1016/j.arr.2023.101921.
M. A. Deli et al., “Lab-on-a-chip models of the blood–brain barrier: evolution, problems, perspectives,” Lab on a Chip, vol. 24, no. 5, pp. 1030–1063, 2024, doi: https://doi.org/10.1039/D3LC00996C.
X. Shao et al., “Development of a blood-brain barrier model in a membrane-based microchip for characterization of drug permeability and cytotoxicity for drug screening,” Analytica Chimica Acta, vol. 934, pp. 186–193, Aug. 2016, doi: https://doi.org/10.1016/j.aca.2016.06.028.
Y. Koo, B. T. Hawkins, and Y. Yun, “Three-dimensional (3D) tetra-culture brain on chip platform for organophosphate toxicity screening,” Scientific Reports, vol. 8, no. 1, Feb. 2018, doi: https://doi.org/10.1038/s41598-018-20876-2.
M. D. Sweeney, Z. Zhao, A. Montagne, A. R. Nelson, and B. V. Zlokovic, “Blood-Brain Barrier: From Physiology to Disease and Back,” Physiological Reviews, vol. 99, no. 1, pp. 21–78, Jan. 2019, doi: https://doi.org/10.1152/physrev.00050.2017.
R. M. Linville et al., “A tissue-engineered model of the blood-tumor barrier during metastatic breast cancer,” Fluids and Barriers of the CNS, vol. 20, p. 80, Nov. 2023, doi: https://doi.org/10.1186/s12987-023-00482-9.
N. A. Boghdeh et al., “Application of a Human Blood Brain Barrier Organ-on-a-Chip Model to Evaluate Small Molecule Effectiveness against Venezuelan Equine Encephalitis Virus,” Viruses, vol. 14, no. 12, p. 2799, Dec. 2022, doi: https://doi.org/10.3390/v14122799.
S. Subramaniyan Parimalam, S. Badilescu, N. Sonenberg, R. Bhat, and M. Packirisamy, “Lab-On-A-Chip for the Development of Pro-/Anti-Angiogenic Nanomedicines to Treat Brain Diseases,” International Journal of Molecular Sciences, vol. 20, no. 24, p. 6126, Jan. 2019, doi: https://doi.org/10.3390/ijms20246126.
A. van den Berg, C. L. Mummery, R. Passier, and A. D. van der Meer, “Personalised organs-on-chips: functional testing for precision medicine,” Lab on a Chip, vol. 19, no. 2, pp. 198–205, 2019, doi: https://doi.org/10.1039/c8lc00827b.
B. L. Marini et al., “Blood-brain barrier–adapted precision medicine therapy for pediatric brain tumors,” Translational research, vol. 188, pp. 27.e1–27.e14, Oct. 2017, doi: https://doi.org/10.1016/j.trsl.2017.08.001.
A. Ghiaseddin et al., “Adult precision medicine: learning from the past to enhance the future,” Neuro-oncology advances, vol. 3, no. 1, Jan. 2021, doi: https://doi.org/10.1093/noajnl/vdaa145.
Ruthwik Guntupalli, Saloni Verma and Karan Dhingra 2024. Impact of Healthcare Digitization: Systems Approach for Integrating Biosensor Devices and Electronic Health with Artificial Intelligence. American Scientific Research Journal for Engineering, Technology, and Sciences. 98, 1 (Aug. 2024), 246–257, https://asrjetsjournal.org/index.php/American_Scientific_Journal/article/view/10786/2789.
T. Blasi et al., “Label-free cell cycle analysis for high-throughput imaging flow cytometry,” Nature Communications, vol. 7, no. 1, Jan. 2016, doi: https://doi.org/10.1038/ncomms10256.
I. Ulitsky, A. Shkumatava, Calvin H. Jan, H. Sive, and David P. Bartel, “Conserved Function of lincRNAs in Vertebrate Embryonic Development despite Rapid Sequence Evolution,” Cell, vol. 147, no. 7, pp. 1537–1550, Dec. 2011, doi: https://doi.org/10.1016/j.cell.2011.11.055.
B. Cui and S.-W. Cho, “Blood-brain barrier-on-a-chip for brain disease modeling and drug testing,” BMB Reports, vol. 55, no. 5, pp. 213–219, May 2022, doi: https://doi.org/10.5483/bmbrep.2022.55.5.043.
X. Chen, C. Liu, Laureana Muok, C. Zeng, and Y. Li, “Dynamic 3D On-Chip BBB Model Design, Development, and Applications in Neurological Diseases,” Cells, vol. 10, no. 11, pp. 3183–3183, Nov. 2021, doi: https://doi.org/10.3390/cells10113183.
“Ageing Research Reviews | Journal | ScienceDirect.com by Elsevier,” www.sciencedirect.com. https://www.sciencedirect.com/journal/ageing-research-reviews
M. D. Sweeney, A. P. Sagare, and B. V. Zlokovic, “Blood–brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders,” Nature Reviews Neurology, vol. 14, no. 3, pp. 133–150, Jan. 2018, doi: https://doi.org/10.1038/nrneurol.2017.188.
A. P. F. Turner, “BIOCHEMISTRY: Biosensors-Sense and Sensitivity,” Science, vol. 290, no. 5495, pp. 1315–1317, Nov. 2000, doi: https://doi.org/10.1126/science.290.5495.1315.
András Kincses et al., “The Use of Sensors in Blood-Brain Barrier-on-a-Chip Devices: Current Practice and Future Directions,” Biosensors, vol. 13, no. 3, pp. 357–357, Mar. 2023, doi: https://doi.org/10.3390/bios13030357.
D. Manojlovic et al., “Effects of a low-shrinkage methacrylate monomer and monoacylphosphine oxide photoinitiator on curing efficiency and mechanical properties of experimental resin-based composites,” Materials science & engineering. C, Biomimetic materials, sensors and systems (Print), vol. 58, pp. 487–494, Jan. 2016, doi: https://doi.org/10.1016/j.msec.2015.08.054.
B. V. Zlokovic, “The Blood-Brain Barrier in Health and Chronic Neurodegenerative Disorders,” Neuron, vol. 57, no. 2, pp. 178–201, Jan. 2008, doi: https://doi.org/10.1016/j.neuron.2008.01.003.
Y. I. Wang, H. E. Abaci, and M. L. Shuler, “Microfluidic blood-brain barrier model provides in vivo-like barrier properties for drug permeability screening,” Biotechnology and Bioengineering, vol. 114, no. 1, pp. 184–194, Jul. 2016, doi: https://doi.org/10.1002/bit.26045.
S. Kumar et al., “Prospects of Biosensors Based on Functionalized and Nanostructured Solitary Materials: Detection of Viral Infections and Other Risks,” ACS omega, vol. 7, no. 26, pp. 22073–22088, Jun. 2022, doi: https://doi.org/10.1021/acsomega.2c01033.
S. K. Srivastava, G. W. Foo, N. Aggarwal, and M. W. Chang, “Organ-on-chip technology: Opportunities and challenges,” Biotechnology Notes, vol. 5, pp. 8–12, Jan. 2024, doi: https://doi.org/10.1016/j.biotno.2024.01.001.
P. Naik and L. Cucullo, “In Vitro Blood–Brain Barrier Models: Current and Perspective Technologies,” Journal of Pharmaceutical Sciences, vol. 101, no. 4, pp. 1337–1354, Apr. 2012, doi: https://doi.org/10.1002/jps.23022.
Downloads
Published
Issue
Section
License
Copyright (c) 2024 Journal of Knowledge Learning and Science Technology ISSN: 2959-6386 (online)
This work is licensed under a Creative Commons Attribution 4.0 International License.
©2024 All rights reserved by the respective authors and JKLST.
Copyright: © The Author(s), 2024. Published by 